United States · FDA National Drug Code directory
CaroSpir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46287-020_341fea14-cdc7-4c75-b1ca-706e90dc0128
- Product NDC
- 46287-020
- Form
- SUSPENSION
- Composition / generic term
- CaroSpir
- Labeler
- CMP Pharma, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20170804
- Source listing expiry
- 20261231
Source-listed ingredients
- SPIRONOLACTONE — 25 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 473 mL in 1 BOTTLE (46287-020-01) · 46287-020-01
- 118 mL in 1 BOTTLE (46287-020-04) · 46287-020-04
- 10 CUP, UNIT-DOSE in 1 CARTON (46287-020-50) / 5 mL in 1 CUP, UNIT-DOSE · 46287-020-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →